Searching for a cure, Improving lives

Campaign Objectives

Action Duchenne are campaigning to ensure:

Vigil 1


1. All children and adults living with Duchenne have opportunities to participate in clinical research and access high quality multidisciplinary care

Research into Duchenne has reached an unprecedented stage, with a tidal wave of emerging treatments now in the pipeline. However, if these are to be developed it is essential the UK has the capacity to host clinical trails, capable of linking patients with innovative emerging drugs and proving the clinical efficacy of said treatments.

Our ‘Joining the Dots’ initiative and partnership in the ‘Newcastle Plan’ therefore aims to develop the capacity of the UK to host clinical trials and ensure every person living with Duchenne in the UK has access to clinical research opportunities and the highest standards of multidisciplinary care.


2. Safe and effective treatments are made available to those living with Duchenne without delay.

In the summer of 2014, Translarna (Ataluren) became the first European Medicines Agency approved treatment to address the underlying causes of Duchenne muscular dystrophy. Since this date we have campaigned tirelessly to ensure this treatment receives funding approval and is made available to all those eligible to benefit.

We are also fighting to ensure that the UK has a quick, robust, transparent and fair process for evaluating future Duchenne treatments, and to guarantee the mistakes, misguidance and inertia displayed in NICE and NHS England in their evaluation of Translarna, cannot be repeated. These efforts extend to focussing upon the regulatory framework of clinical trial and drug approval, encouraging funding for Duchenne research and the development of improved and adaptive regulatory pathways.


3. Everyone living with Duchenne can lead a long a fulfilled adult life 

Despite huge advances in research and the clinical management of Duchenne, a collective failure to acknowledge the potential of every child living with Duchenne has led to many living unfulfilled lives in adulthood.

In addition raising to expectations amongst patients and families, we further inform health, education and social care professionals about the learning and behavioural difficulties associated with Duchenne, and the need for good educational outcomes as a basis for a well rounded adult life.



Support Action Duchenne with a monthly or one off donation



View our events

View All Events


Join the DMD registry for access to clinical trials


Summit to Extend Ongoing PhaseOut DMD Clinical Trial of Ezutromid in Patients with DMD

March 27th, 2017

  Introduction from Michelle Avery (Summit Therapeutics): Today, we’ve announced that we intend to proceed

Tell me more

Amazing London Marathon Dinner at Jamie’s Italian!

February 7th, 2017

  On Saturday 3 February Andrew Parkinson and Andrew Pearson, two of our London Marathon

Tell me more

Positive Preclinical Research on the Edasalonexent (CAT-1004) Program

January 6th, 2017

  Catabasis announced the publication of preclinical data on the edasalonexent program, a potential disease-modifying

Tell me more

Duchenne – How do you measure a life?

Living with Duchenne – an animation

Taking charge of Duchenne

wordpress counter

Stay informed with regular updates from Action Duchenne